NASDAQ:PRXL PAREXEL International (PRXL) Stock Price, News & Analysis → At first glance, this chart looks like nonsense… (From The TradingPub) (Ad) Free PRXL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$88.08▼$88.0850-Day Range$88.08▼$88.0852-Week Range$51.16▼$88.10VolumeN/AAverage Volume1.04 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get PAREXEL International alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About PAREXEL International Stock (NASDAQ:PRXL)PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch. The Company's PI segment provides information technology solutions.Read More Ad Wealthpin ProOne trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. PRXL Stock News HeadlinesAugust 29, 2023 | finance.yahoo.comParexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and DevelopmentJune 23, 2023 | technews.tmcnet.comParexel Announces Updates to Board of DirectorsApril 25, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… May 17, 2023 | thestreet.comParexel to Be Taken Off Market by Private EquityMay 17, 2023 | finance.yahoo.comParexel Appoints Scott Smith, M.D., Ph.D. as New Head of HematologyApril 2, 2023 | thestreet.comParexel International Stock Hits New 52-Week High (PRXL)November 2, 2022 | seekingalpha.comIQVIA Holdings Sees Digital Opportunities, But Debt Drags GrowthOctober 16, 2022 | ca.finance.yahoo.comParexel Recognized by Frost & Sullivan with 2022 Global Customer Value Leadership AwardApril 25, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.September 21, 2022 | finance.yahoo.comParexel’s Peyton Howell Awarded Prestigious PharmaVoice Red JacketSeptember 17, 2022 | technews.tmcnet.comParexel's Peyton Howell Awarded Prestigious PharmaVoice Red JacketSeptember 8, 2022 | finance.yahoo.comParexel’s Jim Anthony Named to 2022 PharmaVOICE 100September 7, 2022 | thestreet.comStarboard's Smith Launches Campaign To Ensure Parexel Finds a BuyerJune 16, 2022 | finance.yahoo.comParexel Expands Patient Access to Clinical Trials Through New Community Alliance NetworkSee More Headlines Receive PRXL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PAREXEL International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:PRXL CUSIP69946210 CIK799729 Webwww.parexel.com Phone+1-781-4879900FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesJosef H. von RickenbachChairman of the Board, Chief Executive OfficerMark A. Goldberg M.D.President, Chief Operating OfficerSimon HarfordChief Financial Officer, Senior Vice PresidentBio & Compensation - Xavier AB FlinoisPresident - PAREXEL InformaticsMichelle GrahamChief Human Resource Officer, Senior Vice PresidentSybrand Pretorius M.D.Senior Vice President, Chief Scientific OfficerDouglas Alexander BattSenior Vice President, General Counsel, SecretaryRoland Andersson Ph.d.Senior Vice President - Clinical Research ServicesChristian Dreger Ph.D.Senior Vice President - Parexel Access and Parexel ConsultingBio & Compensation - David J. GodwinSenior Vice President-Global BusinessMore Executives PRXL Stock Analysis - Frequently Asked Questions What other stocks do shareholders of PAREXEL International own? Based on aggregate information from My MarketBeat watchlists, some companies that other PAREXEL International investors own include Universal Display (OLED), Allergan (AGN), Baidu (BIDU), Gilead Sciences (GILD), ICON Public (ICLR), Intel (INTC), Netflix (NFLX), Royal Bank of Canada (RY) and Skyworks Solutions (SWKS). This page (NASDAQ:PRXL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAREXEL International Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
